247 related articles for article (PubMed ID: 20513592)
21. Molecular imaging in atherosclerosis: FDG PET.
Rosenbaum D; Millon A; Fayad ZA
Curr Atheroscler Rep; 2012 Oct; 14(5):429-37. PubMed ID: 22872371
[TBL] [Abstract][Full Text] [Related]
22. Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.
Rogers IS; Tawakol A
Curr Cardiol Rep; 2011 Apr; 13(2):138-44. PubMed ID: 21274660
[TBL] [Abstract][Full Text] [Related]
23. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
MacAskill MG; Newby DE; Tavares AAS
Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
[TBL] [Abstract][Full Text] [Related]
24. Imaging Carotid Plaque Inflammation Using Positron Emission Tomography: Emerging Role in Clinical Stroke Care, Research Applications, and Future Directions.
McCabe JJ; Evans NR; Gorey S; Bhakta S; Rudd JHF; Kelly PJ
Cells; 2023 Aug; 12(16):. PubMed ID: 37626883
[TBL] [Abstract][Full Text] [Related]
25. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
26. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
[TBL] [Abstract][Full Text] [Related]
27. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
[TBL] [Abstract][Full Text] [Related]
28. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries.
Chen W; Bural GG; Torigian DA; Rader DJ; Alavi A
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):144-51. PubMed ID: 18982324
[TBL] [Abstract][Full Text] [Related]
29. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
30. Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
Boswijk E; Bauwens M; Mottaghy FM; Wildberger JE; Bucerius J
Methods; 2017 Nov; 130():90-104. PubMed ID: 28602809
[TBL] [Abstract][Full Text] [Related]
31. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
[TBL] [Abstract][Full Text] [Related]
32. PET imaging of atherosclerosis.
Tarkin JM; Joshi FR; Rajani NK; Rudd JH
Future Cardiol; 2015; 11(1):115-31. PubMed ID: 25606707
[TBL] [Abstract][Full Text] [Related]
33. Monitoring plaque composition: is it worthwile?
van der Laarse A; van der Wall EE
Int J Cardiovasc Imaging; 2009 Mar; 25(3):259-61. PubMed ID: 19037748
[No Abstract] [Full Text] [Related]
34. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned?
van der Wall EE; Schuijf JD; Jukema JW; Bax JJ; van der Laarse A
Int J Cardiovasc Imaging; 2009 Feb; 25(2):141-4. PubMed ID: 19058028
[No Abstract] [Full Text] [Related]
36. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR?
Chen W; Dilsizian V
J Nucl Med; 2015 Apr; 56(4):503-4. PubMed ID: 25722451
[No Abstract] [Full Text] [Related]
37. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Figueroa AL; Subramanian SS; Cury RC; Truong QA; Gardecki JA; Tearney GJ; Hoffmann U; Brady TJ; Tawakol A
Circ Cardiovasc Imaging; 2012 Jan; 5(1):69-77. PubMed ID: 22038986
[TBL] [Abstract][Full Text] [Related]
38. FDG PET/CT Imaging of Carotid Atherosclerosis.
Ali A; Tawakol A
Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659
[TBL] [Abstract][Full Text] [Related]
39. Imaging unstable plaque.
Sriranjan RS; Tarkin JM; Evans NR; Chowdhury MM; Rudd JH
Q J Nucl Med Mol Imaging; 2016 Sep; 60(3):205-18. PubMed ID: 27273430
[TBL] [Abstract][Full Text] [Related]
40. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
